Member access

4-Traders Homepage  >  Shares  >  SHANGHAI STOCK EXCHANGE  >  Zhejiang CONBA Pharmaceutical Co., Ltd.    600572   CNE000001H86

End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 11/20
16.36 CNY   -0.55%
08/05 ZHEJIANG CONBA PHARMACEUTICAL : H1 Net Up Nearly 40%
04/22 ZHEJIANG CONBA PHARMACEUTICAL : Q1 Net Up 33%
04/08 ZHEJIANG CONBA PHARMACEUTICAL : Conba to Acquire 51% of Baite Pharm at CNY9..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsRevisions 
Business Summary
Develops, manufactures and distributes pharmaceutical products

Zhejiang CONBA Pharmaceutical Co., Ltd. is engaged in the development, production and sale of traditional Chinese medicines, chemical drugs and healthcare products.

Its major products include ginkgo biloba extract, conprosta, capsules, tablets and rhinitis spray.

The company was founded in 1969 and is headquartered in Hangzhou, China.

Number of employees : 7 378 persons.
Sales per Businesses
20122013Delta
CNY (in Million)%CNY (in Million)%
Modern Plant Medicine1,46053.4%1,61655.3% +9.67%
Chemical Medicine879.7132.2%968.4933.2% +9.17%
Raw Materials Medicines205.787.5%184.756.3% -11.38%
Health Products93.813.4%9.560.3% -881.15%
Others Service Income57.932.1%87.193% +33.55%
Other Products36.761.3%55.161.9% +33.35%
Sales per Regions
20122013Delta
CNY (in Million)%CNY (in Million)%
China2,733100%2,921100% +6.44%
Managers
NameAgeSinceTitle
Wei Liang Zhang512008President & Director
Ji Qiang Hu532008Chairman
Zhi Guo Lu562008Chairman-Supervisory Board
Yue Zhong Chen452009Chief Financial Officer & Vice President
Zhong Shi Wu512008Vice Chairman
Shu Xiang Dong50-Director & Vice President
Bo Wen Zhao78-Independent Director
Guo Ping Chen54-Director
Jian Xiang Shi, PhD50-Independent Director
Ji Dong Duan, MD49-Independent Non-Executive Director
Shareholders
NameShares%
Ji Qiang Hu 245,169,18335.0%
Chongqing Conba Venture Capital Co. Ltd. 63,092,6489.00%
Huashang Fund Management Co., Ltd. 53,251,7617.60%
Guotai Asset Management Co., Ltd. 17,078,0192.44%
China International Capital Corp. Ltd. (Invt Management) 10,199,5851.46%
ICBC Credit Suisse Asset Management Co., Ltd. 7,000,0001.00%
Yangkang United Equity Investment LLC 6,956,0000.99%
China Asset Management Co., Ltd. 6,742,2270.96%
Rongtong Fund Management Co., Ltd. 5,800,0000.83%
China Southern Asset Management Co., Ltd. 5,700,0000.81%
Holdings
NameShares%Valuation
Zhejiang Jolly Pharmaceutical Co Ltd (300181) 23,657,53010.6%62,077,122 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
PER
Potential -
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
SUN PHARMACEUTICA..
OTSUKA HOLDINGS C..
ASPEN PHARMACARE ..
BIOMARIN PHARMACE..
ENDO INTERNATIONA..
ONO PHARMACEUTICA..
HOSPIRA, INC.
SHANGHAI FOSUN PH..
SIHUAN PHARMACEUT..
CIPLA LTD
TAISHO PHARMACEUT..
CADILA HEALTHCARE..
CHINA MEDICAL SYS..
LUYE PHARMA GROUP..
-
SICHUAN KELUN PHA..
-
SHENZHEN SALUBRIS..
DIVI'S LABORATORI..
GLENMARK PHARMACE..
XIZANG HAISCO PHA..
SHENZHEN HEPALINK..
-
Sector Pharmaceuticals
Company contact information
Zhejiang CONBA Pharmaceutical Co., Ltd.
568 Binkang Road
Binjiang Technology & Economic Park
Hi-Tech Development Zone
Hangzhou, Zhejiang 310052

Phone : +86.571.87774811
Fax : +86.571.87774722
Web : www.conbagroup.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF